home
about us
member log-in
contact us

PRODUCTS
MUNICIPAL BONDS
INDEX FUNDS
- Total Asset Fund (TAF)
EVENTS
MARKET RESEARCH

Recent Quotes

View Full List

My Watchlist

Indicators

Markets:

Overview

News

Currencies

International

Treasuries

Hologic, Inc. - Common Stock (NQ:HOLX)

75.59 +0.04 (+0.05%)

Streaming Delayed Price Updated: 4:00 PM EDT, Mar 31, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Hologic, Inc. - Common Stock

< Previous 1 2

...

7 8 9 10 11 12 13 14 15

...

17 18 Next >

Earnings Scheduled For July 31, 2023 ↗

July 31, 2023

Companies Reporting Before The Bell • Immunogen (NASDAQ:IMGN) is estimated to report quarterly loss at $0.16 per share on revenue of $42.84 million.

Via Benzinga

Hologic's Earnings: A Preview ↗

July 28, 2023

Via Benzinga

3 Top Analyst Picks Worth Your Attention Now ↗

July 17, 2023

These top analyst picks, offering robust upside ahead, represent a beacon amidst the stock market chaos at this time.

Via InvestorPlace

Benzinga's Top Ratings Upgrades, Downgrades For July 14, 2023 ↗

July 14, 2023

Via Benzinga

Hologic to Announce Financial Results for the Third Quarter of Fiscal 2023 on Monday, July 31, 2023

July 05, 2023

From Hologic, Inc.

Via Business Wire

Expert Ratings for Hologic ↗

June 15, 2023

Via Benzinga

What 9 Analyst Ratings Have To Say About Hologic ↗

May 03, 2023

Via Benzinga

Earnings Preview For Hologic ↗

April 28, 2023

Via Benzinga

Illumina Takes AI to Genomics: Launch of PrimateAI-3D for Accurate Disease Prediction ↗

June 02, 2023

Illumina, Inc. (NASDAQ: ILMN) launched PrimateAI-3D, an artificial intelligence (AI) algorithm that predicts disease-causing genetic mutations in patients.

Via Benzinga

Hologic Announces FDA Clearance of Panther Fusion SARS-CoV-2/Flu A/B/RSV Assay

May 19, 2023

From Hologic Inc.

Via Business Wire

Time To Play Small Cap Life Science Stocks ↗

May 15, 2023

The overall market sentiment has been hit hard by MACRO concerns. The dominating narrative is the Fed and the Debt Ceiling.

Via Talk Markets

A New Groundbreaking Tool to Detect Colon Cancer Earlier

May 10, 2023

A novel blood test for detecting colon cancer, the third most lethal type of cancer in the US, has been created. The Colorectal Cancer Screening Blood Test can identify cancer at early stages. This...

Via PressReach

Cowen & Co. Maintains Outperform Rating for Hologic: Here's What You Need To Know ↗

February 02, 2023

Via Benzinga

Hologic Announces Partnership with NFL Rookie Kelee Ringo and Family

May 08, 2023

From Hologic Inc.

Via Business Wire

Market Rally Finishes Strong; Regional Banks, Fed Rate Hike, Jobs Report, Apple In Focus: Weekly Review ↗

May 05, 2023

The major indexes retreated for most of the week on banking fears,

Via Investor's Business Daily

Hologic to Webcast Presentation at the BofA Securities 2023 Healthcare Conference

May 02, 2023

From Hologic, Inc.

Via Business Wire

Can Butterfly Network Spread its Wings in 2023?

May 02, 2023

Butterfly Network Inc. (NYSE: BFLY) is a medical imaging solutions company that makes point-of-demand portable ultrasound devices to bring medical imaging to h

Via MarketBeat

Topics Artificial Intelligence

Hologic Announces Financial Results for Second Quarter of Fiscal 2023

May 01, 2023

From Hologic, Inc.

Via Business Wire

Earnings Scheduled For May 1, 2023 ↗

May 01, 2023

Companies Reporting Before The Bell • TG Therapeutics (NASDAQ:TGTX) is estimated to report quarterly loss at $0.37 per share on revenue of $3.38 million.

Via Benzinga

Hologic to Announce Financial Results for the Second Quarter of Fiscal 2023 on Monday, May 1, 2023

April 03, 2023

From Hologic, Inc.

Via Business Wire

Biotech And Life Science Trades: Q1 2023 Performance By The Numbers ↗

April 01, 2023

Despite a strong month and a great finish to the quarter, many traders remain cautious about the market. It’s been a volatile time after the collapse of Silicon Valley Bank, but the first quarter of...

Via Talk Markets

Evolution of Oncology Treatments Giving New Hope to Those Diagnosed with Breast Cancer

March 24, 2023

FN Media Group Presents USA News Group News Commentary Vancouver, BC – March 24, 2023 – USA News Group – Treatments for various forms of breast cancer continue to evolve, with several new breakthroughs...

Via FinancialNewsMedia

Hologic to Webcast Presentation at the Cowen 43rd Annual Health Care Conference

February 28, 2023

From Hologic, Inc.

Via Business Wire

Hologic “Making a World of Difference” Through Global Sustainability Impact

February 21, 2023

From Hologic, Inc.

Via Business Wire

SMID Cap Life Science Update: Are You An Investor Or Trader? ↗

February 20, 2023

Despite choppy trading, there is an upward tilt to life science stocks since the 9/26/22 lows.

Via Talk Markets

Court of Appeals Affirms District Court Decision Invalidating Minerva Surgical Patent

February 17, 2023

From Hologic Inc.

Via Business Wire

Image-Guided Biopsy Market Is Expected to Reach at High CAGR of 5.49% by 2022-2029

February 07, 2023

[180 Pages Report] Image-Guided Biopsy Market size was valued at US$ YY million in 2021 and is estimated to reach US$ YY million by 2029, growing at a CAGR of 5.49 % during the forecast period...

Via SBWire

When Small Cap Biotechs Lose Momentum: Are You An Investor Or A Trader? ↗

February 05, 2023

A few small cap biotechs lost momentum last week so now might be the time to take profits. But many of these stocks are favored because of their core technology and favored by funds; time to buy?

Via Talk Markets

Hologic Announces Financial Results for First Quarter of Fiscal 2023

February 01, 2023

From Hologic, Inc.

Via Business Wire

Earnings Scheduled For February 1, 2023 ↗

February 01, 2023

Companies Reporting Before The Bell • Novo Nordisk (NYSE:NVO) is expected to report quarterly earnings at $0.85 per share on revenue of $6.84 billion.

Via Benzinga

< Previous 1 2

...

7 8 9 10 11 12 13 14 15

...

17 18 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.

Home
About Us
Products
Municipal Bonds
Index Funds
Seminars & Events
Market Research
Contact Us
Member Section
Privacy Policy
Terms & Conditions
Security Notice
Customer Service

Securities offered through Purshe Kaplan Sterling Investments, member FINRA / SIPC, Headquartered at 80 State Street,
Albany, NY 12207
Purshe Kaplan Sterling Investments and Tamar Securities, LLC are not affiliated companies.
Tamar Securities, LLC is a Registered Investment Adviser. Advisory services are only offered to clients or prospective clients where Tamar Securities, LLC
and its representatives are properly licensed or exempt from licensure. Past performance is no guarantee of future returns. Investing involves risk and possible loss of principal capital.
No advice may be rendered by Tamar Securities, LLC unless a client service agreement is in place.

NOT FDIC INSURED. NOT BANK GUARANTEED. MAY LOSE VALUE, INCLUDING LOSS OF PRINCIPAL. NOT INSURED BY ANY STATE OR FEDERAL AGENCY.
Web development by IBCnet.com